«Lag time» in retinoblastoma diagnosis in Ukraine (clinical cases)
DOI:
https://doi.org/10.31288/oftalmolzh20146512Keywords:
retinoblastoma, lag time, ease clinical casesAbstract
Introduction. «Lag time» — is the time interval between the appearance of a child's first symptoms and the correct diagnosis of retinoblastoma.
Purpose. To present the «lag time» typical clinical variants in Ukraine and their impact on retinoblastoma stage, treatment tactic and outcome.
Material and methods. 5 typical variants of «lag time» manifestation were chosen from 223 retinoblastoma cases in Ukraine.
Results. Long lag-time from 4 to 14 months was observed in 4 patients and associated with parents neglect to first symptoms, treatment by non-traditional methods, incorrect diagnosis by local ophthalmologist, lack or inadequate treatment. As a result, advanced retinoblastoma stage was diagnosed at admission to the Institute that's why the only possible treatment was enucleation (3) and exenteration (1). Retinoblastoma was diagnosed at an early stage in 1 child with a short lag-time, salvage eye treatment was performed with eye and vision preservation. Life survival achieved in 2 cases.
Conclusion. Program for the early retinoblastoma detection should include informing of parents and physicians, who work with the child population, about dis-symptoms and the need of urgent referral to the specialized ophthalmologicalcenter for correct management.
References
1.Bobrova NF, Sorochinskaia TA. Combined (intravitreal and intravenous) polychemotherapy in the system of organ-preserving treatment of retinoblastoma. Oftalmol Zh. 2011;2:38- 44. Russian.https://doi.org/10.31288/oftalmolzh201123844
2.Bobrova NF, Sorochinskaia TA. Local intravitreal chemotherapy in combined treatment of high risk retinoblastoma. Proceedings of Conference «Filatov Reedings», Odessa,2012.
3.Bobrova NF, Sorochinskaia TA, Naumenko VO, Tronina SA, Dembovetska GM. Diagnosis and treatment of children with malignant tumor of the retina - retinoblastoma in Ukraine (protocols). Oftalmol Zh. 2012;1:80-5. Ukrainian.https://doi.org/10.31288/oftalmolzh201218084
4.Bobrova NF, Sorochinskaia TA, Tronina SA et al. Analysis «Lag time»in diagnosis of retinoblastoma in Ukraine. Oftalmol Zh. 2014;4:59- 65. Russian.https://doi.org/10.31288/oftalmolzh201445965
5.Abramson DH, Beaverson K, Sangani P et al. Screening for Retinoblastoma: Presenting Signs as Prognosticators of Patient and Ocular Survival. Pediatrics - 2003 Dec; 112(6 Pt 1):1248-55.https://doi.org/10.1542/peds.112.6.1248
6.Chantada GL, Luna-Fineman S, Quaddoumi I et al. Reti-noblastoma in developing countries in: Retinoblastoma. Springer Science+Business Media, LLC 2010. New York, NY 10013, USA. - P. 133-141.https://doi.org/10.1007/978-0-387-89072-2_11
7.Chantada GL. Retinoblastoma: Lessons and challenges from developing countries. Ellsworth Lecture 2011. Ophthalmic Genetics, 2011; 32(4): 196- 203.https://doi.org/10.3109/13816810.2011.592173
8.Goddard AG, Kingston JE, Hungerford JL. Delayed in diagnosis of retinoblastoma: risk factors and treatment outcome. Br. J Ophthalmol, 1999; 83:1320- 1323.https://doi.org/10.1136/bjo.83.12.1320
9.Leander C, Fu LC, Pena A et al. Impact of an education program on late diagnosis of retinoblastoma in Hounduras.Pediatr Blood Cancer, 2007; 49(6):817-819.https://doi.org/10.1002/pbc.21052
10.Rodrigues KES, Latorre MR, Camargo B. Delayed diagnosis in retinoblastoma. Jornal de Pediatria.2004;80(6) https://doi.org/10.1590/S0021-75572004000800014
11.Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG. Macular Retinoblastoma: Evaluation of Tumor Control, Local Complications, and Visual Outcomes for Eyes Treated with Chemotherapy and Repetitive Foveal Laser Ablation. Ophthalmology. 2007;114:162-9 https://doi.org/10.1016/j.ophtha.2006.06.042
Downloads
Published
Issue
Section
License
Copyright (c) 2014 Н. Ф. Боброва, Т. А. Сорочинская, С. А. Тронина, А. Н. Дембовецкая, Л. А. Суходоева, И. М. Левицкий, Н. Б. Трофимова
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
